Search research articles
Contact Us
Filters
Showing results (201-210 of 247) with videos related to
Page
of 25
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 18, 2015
Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation
Kirsten M Williams, Guang-Shing Cheng, Iskra Pusic, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 9, 2016
Translation, Cross-Cultural Adaptation, and Validation of the Lee Chronic Graft-versus-Host Disease Symptom Scale in a Brazilian Population
Clarissa Vasconcellos de Souza, Afonso Celso Vigorito, Eliana C M Miranda, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 10, 2002
Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome after conditioning with busulfan and fractionated total body irradiation is associated with low relapse rate but considerable nonrelapse mortality
Manuel Jurado, H Joachim Deeg, Barry Storer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 9, 2014
Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial
Lauri M Burroughs, Eneida R Nemecek, Troy R Torgerson, et al.
The Lancet. Haematology
|
June 29, 2019
Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial
Brenda M Sandmaier, Brian Kornblit, Barry E Storer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 13, 2018
Blood and Marrow Transplant Clinical Trials Network Report on the Development of Novel Endpoints and Selection of Promising Approaches for Graft-versus-Host Disease Prevention Trials
Marcelo C Pasquini, Brent Logan, Richard J Jones, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 24, 2007
Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia
Daniella M B Kerbauy, Theodore A Gooley, George E Sale, et al.
Bone Marrow Transplantation
|
August 28, 2003
Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation
Chien-Shing Chen, M Boeckh, K Seidel, et al.
Blood
|
March 10, 2009
Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease
Paul J Martin, Barry E Storer, Scott D Rowley, et al.
Blood Advances
|
October 25, 2024
Ibrutinib for therapy of steroid-refractory chronic graft-versus-host disease: a multicenter real-world analysis
Joseph Pidala, Jongphil Kim, Denise Kalos, et al.
Page
of 25
Search research articles
Search
Showing results (201-210 of 247) with videos related to
Sort By:
Page
of 25
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 18, 2015
Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation
Kirsten M Williams, Guang-Shing Cheng, Iskra Pusic, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 9, 2016
Translation, Cross-Cultural Adaptation, and Validation of the Lee Chronic Graft-versus-Host Disease Symptom Scale in a Brazilian Population
Clarissa Vasconcellos de Souza, Afonso Celso Vigorito, Eliana C M Miranda, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 10, 2002
Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome after conditioning with busulfan and fractionated total body irradiation is associated with low relapse rate but considerable nonrelapse mortality
Manuel Jurado, H Joachim Deeg, Barry Storer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 9, 2014
Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial
Lauri M Burroughs, Eneida R Nemecek, Troy R Torgerson, et al.
The Lancet. Haematology
|
June 29, 2019
Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial
Brenda M Sandmaier, Brian Kornblit, Barry E Storer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 13, 2018
Blood and Marrow Transplant Clinical Trials Network Report on the Development of Novel Endpoints and Selection of Promising Approaches for Graft-versus-Host Disease Prevention Trials
Marcelo C Pasquini, Brent Logan, Richard J Jones, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 24, 2007
Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia
Daniella M B Kerbauy, Theodore A Gooley, George E Sale, et al.
Bone Marrow Transplantation
|
August 28, 2003
Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation
Chien-Shing Chen, M Boeckh, K Seidel, et al.
Blood
|
March 10, 2009
Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease
Paul J Martin, Barry E Storer, Scott D Rowley, et al.
Blood Advances
|
October 25, 2024
Ibrutinib for therapy of steroid-refractory chronic graft-versus-host disease: a multicenter real-world analysis
Joseph Pidala, Jongphil Kim, Denise Kalos, et al.
Page
of 25